ANRO · Alto Neuroscience, Inc.
AI read · Neutral
The AI's read
The plan was in place before the sale, so the transaction is less likely to reflect a fresh view of Alto. The report describes no change to the company's work or results.
Alto Neuroscience COO Michael Hanley sold 75,000 shares for $2,070,389 under a plan adopted August 14, 2026. Because the plan came first, the sale does not show a new change in Alto's business outlook.
The plan was in place before the sale, so the transaction is less likely to reflect a fresh view of Alto. The report describes no change to the company's work or results.
Follow Alto Neuroscience, Inc. (ANRO) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ANRO